Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation
about
Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair.Murine models of inflammatory bowel disease (IBD): challenges of modeling human diseaseExpression of the Blood-Group-Related Gene B4galnt2 Alters Susceptibility to Salmonella InfectionComparisons between myeloperoxidase, lactoferrin, calprotectin and lipocalin-2, as fecal biomarkers of intestinal inflammation in malnourished children.Chemical and pathogen-induced inflammation disrupt the murine intestinal microbiome.Homeostasis of the gut barrier and potential biomarkers.Serum miRNA signature diagnoses and discriminates murine colitis subtypes and predicts ulcerative colitis in humans.AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition.Ron receptor-dependent gene regulation of Kupffer cells during endotoxemia.Proneness of TLR5 deficient mice to develop colitis is microbiota dependent.Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice.Innate immune detection of flagellin positively and negatively regulates salmonella infection.Dextran sodium sulfate inhibits the activities of both polymerase and reverse transcriptase: lithium chloride purification, a rapid and efficient technique to purify RNA.Strict vegetarian diet improves the risk factors associated with metabolic diseases by modulating gut microbiota and reducing intestinal inflammation.Longitudinal study of circulating protein biomarkers in inflammatory bowel disease.Gut microbiota, low-grade inflammation, and metabolic syndrome.Antibiotic treatment suppresses rotavirus infection and enhances specific humoral immunity.Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndromePersistent Organic Pollutants Modify Gut Microbiota-Host Metabolic Homeostasis in Mice Through Aryl Hydrocarbon Receptor Activation.Characterization of Changes in Global Genes Expression in the Distal Colon of Loperamide-Induced Constipation SD Rats in Response to the Laxative Effects of Liriope platyphylla.Lack of soluble fiber drives diet-induced adiposity in miceNeutrophil gelatinase-associated lipocalin regulates gut microbiota of mice.The Effect of Cigarette Smoke Exposure on the Development of Inflammation in Lungs, Gut and Joints of TNFΔARE MiceIron Homeostasis and Inflammatory Status in Mice Deficient for the Cystic Fibrosis Transmembrane Regulator.Gene expression profiling in necrotizing enterocolitis reveals pathways common to those reported in Crohn's disease.Inhibition of Interleukin-10 Signaling Induces Microbiota-dependent Chronic Colitis in Apolipoprotein E Deficient Mice.Maternal IgG and IgA Antibodies Dampen Mucosal T Helper Cell Responses in Early Life.Tissue adaptation of regulatory and intraepithelial CD4⁺ T cells controls gut inflammation.Biomarkers of Inflammatory Bowel Disease: From Classical Laboratory Tools to Personalized MedicineAdherent-Invasive Escherichia coli Production of Cellulose Influences Iron-Induced Bacterial Aggregation, Phagocytosis, and Induction of Colitis.Escherichia coli heme oxygenase modulates host innate immune responses.Low dietary iron intake restrains the intestinal inflammatory response and pathology of enteric infection by food-borne bacterial pathogens.CD40-signalling abrogates induction of RORγt+ Treg cells by intestinal CD103+ DCs and causes fatal colitisIntestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunctionThe potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases.Absence of MHC class II on cDCs results in microbial-dependent intestinal inflammationLipocalin 2 alleviates iron toxicity by facilitating hypoferremia of inflammation and limiting catalytic iron generationMetabolomics Reveals that Aryl Hydrocarbon Receptor Activation by Environmental Chemicals Induces Systemic Metabolic Dysfunction in Mice.Food Additive P-80 Impacts Mouse Gut Microbiota Promoting Intestinal Inflammation, Obesity and Liver DysfunctionMicrobiota-inducible Innate Immune, Siderophore Binding Protein Lipocalin 2 is Critical for Intestinal Homeostasis.
P2860
Q24318444-EA46249B-B9C3-4652-AF2B-DCE8656EAC9FQ26863622-19AAC276-17AD-49E3-9CE8-F7D048BFE2AFQ27318788-E6082143-8171-4422-9681-905FE5F270A1Q30275717-6A76C2BA-9030-4389-859E-FF77DB9412ECQ33612677-B5515A9B-ACAB-4F49-87A2-B04A2FE91C4DQ33715804-73AA9AB7-CC30-4A9D-A45B-4DAE11C818B7Q33746984-8AE1DDA9-BDA8-4F11-8F2F-AD1F38A1D752Q33872260-8995DA76-D9E8-4628-AACA-A43A95953309Q33940416-F0654878-32EB-48A7-86A9-76A641EA76E0Q34480383-BCF430B6-1633-4CE1-B1B0-E6706D84C300Q34619950-D27239BE-3D5C-4B08-B3D6-046164E37406Q34972958-C1575F1E-9752-47BD-AAC3-FA71C6BB7B0DQ34980263-4A1117B0-A676-451B-8FAF-9EC0FCB4BFA4Q35014189-8E5C21EE-1CF3-4DB7-90C6-B19C6775CD36Q35032838-8E08FE64-76B8-424A-B229-421E0B5D8D1DQ35055922-8EE92408-F5AA-4A53-88B0-4B3F9C9FBB5CQ35443349-CB3763E4-C04F-4F46-925A-F2A4A606A68FQ35570155-B6C1BFB5-5239-454E-A572-EA8DBEE5A42EQ35576758-4E57C69F-CF18-4E7C-AB52-F924352C1547Q35685299-5AD9F61F-A474-46AB-89B6-47BE28AB73CEQ35694245-8CFE0A9C-D48A-4654-A20B-CE8C01DFD654Q35696770-9C404C8F-840B-4570-9D45-6B5F9BCAF5F6Q35829049-155A3D00-7D0B-4463-B83D-C5F52AF66040Q35879466-0CD0A3DE-B2B9-4894-9433-13A121EB508EQ35902166-16DDBD5D-E61D-4192-BE8A-D7A7CB43722DQ35927509-E28423D9-C1E4-4068-9864-C2862186C0DFQ36011031-5A8CBA42-F27C-4CAF-84E8-F6A07CD9CEEEQ36039020-654DA105-250E-4AA6-B97E-8A2A82B0B24AQ36052700-A0F64202-468D-44D7-8402-C861E9CB9335Q36053474-8FA47ACF-8052-41F9-9246-44672798F7BEQ36091995-1E46B2EC-5DA5-4C27-AB2D-C686F22E9A83Q36202128-F0E8B485-8114-4144-B062-0FFFA7860FE8Q36301790-0F695EF0-786D-46CE-84A4-C885F278A8D6Q36379436-24601DDE-D769-4E72-A1EF-2349C5C15C9EQ36762507-646266DE-F511-4493-87D6-2C0B61348278Q36767470-2B2B293B-7020-4066-A992-585E375F4576Q36936201-E0DF0F52-B437-405D-9312-C74E79901601Q36959793-04060F68-6DDA-4D5A-A12D-039124232AE6Q37094870-79C5326E-8296-46EF-A8C0-71ACBD657167Q37119613-705B3BF1-F608-4959-83E4-FF4A5958227E
P2860
Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Fecal lipocalin 2, a sensitive ...... er for intestinal inflammation
@ast
Fecal lipocalin 2, a sensitive ...... er for intestinal inflammation
@en
Fecal lipocalin 2, a sensitive ...... er for intestinal inflammation
@nl
type
label
Fecal lipocalin 2, a sensitive ...... er for intestinal inflammation
@ast
Fecal lipocalin 2, a sensitive ...... er for intestinal inflammation
@en
Fecal lipocalin 2, a sensitive ...... er for intestinal inflammation
@nl
prefLabel
Fecal lipocalin 2, a sensitive ...... er for intestinal inflammation
@ast
Fecal lipocalin 2, a sensitive ...... er for intestinal inflammation
@en
Fecal lipocalin 2, a sensitive ...... er for intestinal inflammation
@nl
P2093
P2860
P1433
P1476
Fecal lipocalin 2, a sensitive ...... er for intestinal inflammation
@en
P2093
Andrew N Young
Andrew T Gewirtz
Gayathri Srinivasan
Maria A Delgado
Matam Vijay-Kumar
P2860
P304
P356
10.1371/JOURNAL.PONE.0044328
P407
P577
2012-09-05T00:00:00Z